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Abstract 
Feline calicivirus (FCV) is one of the most common viral pathogens in domestic cats 
worldwide. The variable regions of the capsid (VP1) gene of FCV have one of the 
highest recorded rates of molecular evolution and therefore favouring rapid viral 
evolution. In this study we undertook, for the first time, phylogenetic analyses using 
the near-complete capsid gene. Sequences from 66 Swiss FCV isolates were used 
to investigate the correlation between viral phylogeny and several traits (i.e. 
geographic origin, signalment, husbandry and FCV vaccination). Codon-based 
nucleotide alignment showed that individual nucleotides and their corresponding 
amino acid sites were either invariant or highly variable. Using a threshold of 20% 
genetic distance in the variable region E, FCV isolates grouped in 52 strains, 10 of 
which comprised 2 to 3 isolates. Two well-supported lineages (named 1 and 2) were 
found and contained 9 and 24 isolates, respectively. A strong association between 
cat pedigree status and FCV genetic diversity was found. Most of the FCV isolates 
from pedigree cats belonged to lineage 2. Possible explanations for the existence of 
genetically related FCV isolates in pedigree cats include a shared transmission route 
or genetic characteristics of pedigree cats that might increase susceptibility to certain 
FCV strains. The phylogenetic resolution in the present study surpassed that of 
previous ones due to the inclusion of longer and more conserved sequences. 
Key words: Feline calicivirus, pedigree cat, phylogenetic analyses, trait-correlation, 
capsid (VP1) gene 
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Zusammenfassung 
Feline Caliciviren (FCV) gehören zu den häufigsten viralen Pathogenen bei Katzen 
weltweit. Die variable Region des Kapsidgenes (VP1) von FCV weist eine der 
höchsten Evolutionsraten für Viren auf, was zu einer schnellen genetischen 
Weiterentwicklung von FCV führt. In dieser Studie wurden zum ersten Mal 
phylogenetische Analysen basierend auf dem fast kompletten Kapsidgen 
durchgeführt. Die Sequenzen von 66 Schweizer FCV Isolaten wurden erhoben und 
die Phylogenie mit diversen Merkmalen der Katzen (geografische Herkunft, 
Signalment, Haltungsformen, FCV Impfung) korreliert. Das Codon-basierte Nukleotid 
Alignment zeigte, dass die einzelnen Nukleotide und die korrespondierenden 
Aminosäuren entweder identisch oder sehr variabel waren. Basierend auf einer 
genetischen Distanz über 20% in der variablen Region E des Kapsidgenes wurden 
die Isolate in 52 Stämme eingeteilt, wobei zehn Stämme zwei bis drei Isolate 
enthalten. Der phylogenetische Baum zeigte zwei gut unterstützte 
Abstammungslinien (1 und 2), die 9 respektive 24 Isolate enthalten. Es wurde eine 
starke Assoziation zwischen Reinrassigkeit und FCV Phylogenie gefunden. Fast alle 
Isolate von Rassekatzen gruppierten in die Abstammungslinie 2. Ein gemeinsamer 
Übertragungsweg oder die genetische Konstitution sind mögliche Erklärungen für 
das Vorkommen von genetisch verwandten FCV Isolaten in Rassekatzen. Die 
phylogenetische Auflösung war höher als in bisherigen Studien aufgrund der Analyse 
von längeren und konservierteren Sequenzen. 
Schlüsselwörter: Felines Calicivirus, Rassekatzen, phylogenetische Analysen, 
Merkmal-Korrelation, Kapsid (VP1 ) Gen
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Abstract 
Feline calicivirus (FCV) is one of the most common viral pathogens in domestic cats 
worldwide. The variable regions of the capsid (VP1) gene of FCV have one of the 
highest recorded rates of molecular evolution, favouring rapid viral evolution and 
possibly supporting the emergence of novel, occasionally highly virulent strains. In 
this study, we undertook, for the first time, phylogenetic analyses using nearly 
complete capsid (VP1) gene sequences. Sequences from 66 Swiss FCV isolates 
were used to investigate the correlation between viral phylogeny and several traits, 
including geographic origin, signalment, husbandry, FCV vaccination, and co-
infections. Codon-based nucleotide alignment showed that individual nucleotides and 
their corresponding amino acid sites were either invariant or highly variable. Using a 
threshold of 20% genetic distance in variable region E, FCV isolates were grouped 
into 52 strains, 10 of which comprised 2 to 3 isolates. Two well-supported lineages 
(named 1 and 2) were found and contained 9 and 24 isolates, respectively. A strong 
association between cat pedigree status and FCV genetic diversity was found; most 
of the pedigree cats were Maine Coons. Ancestral character state estimation showed 
that most (17/21) of the FCV isolates from pedigree cats belonged to lineage 2. No 
correlation between viral genetic distances and geographic distances was evident. 
Possible explanations for the existence of genetically related FCV isolates in 
pedigree cats include a shared transmission route (e.g., infection during cat shows) 
or genetic characteristics of pedigree cats that might increase their susceptibility to 
certain FCV strains.  
 
Importance: Understanding the genetic diversity and phylogeny of FCV is a 
prerequisite to exploring the epidemiology and pathogenesis of this virus and to the 
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development of efficacious vaccine strategies. In this study, we undertook a 
nationwide molecular characterization of FCV using nearly complete capsid (VP1) 
gene sequences. We found significant associations between FCV phylogeny and 
host characteristics, specifically the pedigree status of the cats, and we identified two 
well-supported lineages in which the current FCV strain definition was confounded. 
The greater resolution of the FCV phylogeny in this study compared to previous 
studies can be attributed to our use of more conserved regions of the capsid (VP1) 
gene; nonetheless, our results were still hampered by sequence saturation. The 
study highlights the need for whole genome sequences for FCV phylogeny studies.  
Key words: Feline calicivirus, pedigree cat, phylogenetic analyses, trait correlation, 
capsid (VP1) gene, hypervariable region E, strain 
Introduction 
Feline calicivirus (FCV) is a single-stranded, non-enveloped RNA virus belonging to 
the genus Vesivirus within the family Caliciviridae (1). Three other genera are 
assigned to the Caliciviridae, namely the genera Sapovirus, Lagovirus and Norovirus. 
Some of these genera contain highly virulent species, for example rabbit 
hemorrhagic disease virus or human norovirus, which is a major cause of 
gastroenteritis in adults and children (2). FCV is one of the most common viral 
pathogens of cats worldwide, and infections are associated with mucosal and 
cutaneous ulcerations, chronic oral inflammatory disease (gingivitis/stomatitis), 
pneumonia and a limping syndrome (3). Furthermore, outbreaks of highly virulent 
systemic FCV infections have been reported, first in the USA (4-6) and subsequently 
also in Europe (7-11). Affected cats develop a systemic inflammatory response 
syndrome and show high fever, subcutaneous oedema and skin ulcerations. Mortality 
rates of up to 60% have been reported for this syndrome (12). Despite these highly 
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virulent cases, asymptomatic FCV infections have been described, and up to 21% of 
healthy cats have been reported to test PCR-positive for FCV (13-15). Viral 
characteristics and host-specific factors are both thought to play a role in the 
development of FCV-associated disease. Several studies have tried to identify FCV 
nucleotide or amino acid sequence variations that are unique to different disease 
manifestations, but the genetic basis of FCV pathogenicity remains unresolved (11, 
16-19). 
The FCV genome comprises a 7.7 kb positive−sense RNA molecule that encodes 
three open reading frames (ORF). ORF 1 forms the viral replication complex, ORF 3 
encodes the minor structural protein VP2 and ORF 2 encodes the major capsid 
protein VP1. ORF 2 can further be divided into six regions, A−F. Regions B, D and F 
are more conserved, whereas regions A, C and E are variable (1). Region E contains 
two hypervariable regions that are separated by a conserved domain (1). Variable 
regions C and E of the capsid gene exhibit one of the highest evolutionary rates 
reported for RNA viruses (20). These regions are of particular interest because they 
contain major neutralizing epitopes that define FCV antigenicity (21, 22). 
Furthermore, strain definition and phylogenetic analyses of FCV isolates have been 
based on variable regions C and E. Previous studies showed that epidemiologically 
related FCV isolates differ at less than 20% of the nucleotide sites in the C and E 
regions of the capsid (VP1) gene (23-26). Based on this 20% genetic distance 
threshold for FCV strain definition, remarkably high strain diversity was identified in 
the cat population in the UK and other European countries (27, 28). Phylogenetic 
analyses of variable regions C and E have been hampered by a lack of phylogenetic 
signal above the strain level caused by sequence saturation (27, 28). Previous 
studies were unable to draw reliable conclusions concerning phylogenetic 
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relationships above the strain level or to correlate FCV phylogeny with clinical 
syndromes or the geographic location of infected cats (27, 29, 30).  
To overcome this limitation, in this study, we undertook a nationwide molecular 
characterization of FCV isolates using the nearly complete capsid (VP1) gene, which 
includes the more conserved regions B, D and F of the capsid (VP1) gene. We 
sequenced a total of 66 FCV isolates from cats from 17 cantons of Switzerland that 
showed different clinical manifestations of FCV infection. We investigated the 
association between FCV gene sequences and the location, signalment, husbandry, 
clinical signs and vaccination history of the cats.  
Materials and methods 
Study setup, sample collection and processing 
The samples available for this study were collected during a nationwide FCV study 
that aimed to obtain a large collection of FCV isolates from symptomatic and 
asymptomatic cats in Switzerland (13). For this purpose, oropharyngeal cytobrushes, 
and nasal and conjunctival swabs were collected from 200 cats with suspected FCV 
infection and from 100 healthy cats in 24 veterinary practices in 17 cantons of 
Switzerland (13). Only one cat per owner was included. Cats that had been 
vaccinated within 21 days prior to collection were excluded. Samples from each cat 
were pooled, and total nucleic acid (TNA) was extracted as described (13). The data 
available for each cat contained information on the geographic origin, demographic 
data (age, sex, reproductive status, pedigree and breed), husbandry data (type of 
husbandry, such as private, cat breeder and others, group housing, outdoor access), 
vaccination history, medical treatments and clinical signs (13). Two suspected FCV 
cases (isolates 65 and 185) showed clinical signs resembling virulent systemic 
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disease; genetic data from these cats were obtained during a previous study (11). To 
compare our genetic data with that of commercial FCV vaccine strains, RNA was 
extracted from two commercial FCV vaccines (Feligen® CRP, Virbac, Glattbrugg, 
Switzerland; Nobivac® Tricat III, MSD Animal Health GmbH, Luzern, Switzerland). 
The vaccine material was resuspended in 280 μL of RNase/DNase-free molecular 
biology grade water (Axon Lab AG, Baden, Switzerland), and RNA was extracted 
using a QIAamp® Viral RNA kit (Qiagen, Hombrechtikon, Switzerland) according to 
the manufacturer's instructions.  
Real-time qPCR and real-time RT-qPCR assays 
Within the previous study (13), TNA was tested for the presence of FCV with two 
published real-time reverse-transcriptase (RT) quantitative (q) PCR assays (31, 32), 
named S1 and S2, that were recently optimized (13). All cats that tested positive in at 
least one of the two RT-qPCR runs were categorized as FCV-positive. Moreover, for 
each sample, the results for the detection of FHV-1, Chlamydia felis, Mycoplasma 
felis and Bordetella bronchiseptica by real-time qPCR assays were available (13). All 
real-time qPCR assays were run on an ABI 7500Fast Real-Time PCR system 
(Applied Biosystems, Rotkreuz, Switzerland). Negative and positive controls were 
included in each PCR run. 
Synthesis of cDNA, conventional PCR amplification and sequencing 
FCV-positive samples with high viral loads (cycle threshold values < 30.0; n = 75) in 
RT-qPCR S1 or S2 and RNA extracted from the two commercial FCV vaccines 
(Feligen® CRP, Virbac; Nobivac® Tricat III, MSD Animal Health GmbH) were used 
for sequencing (13). For this purpose, cDNA was synthesized using a High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems) under the following conditions: 
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10 min 25°C, 120 min 37°C, 10 min 70°C. The reaction mixture consisted of 2.5 μl 
10× RT Buffer, 2.5 μl 10× RT random primers, 1.0 μL 25× dNTP Mix (100 mM), 1.25 
μL MultiScribe® Reverse Transcriptase (50 U/μL), 0.3125 μL RNasin® Plus RNase 
Inhibitor (40 U/μL) (Promega AG, Dübendorf, Switzerland), and 10 μL template TNA, 
brought up to 25 μL with RNase/DNase-free molecular biology grade water (Axon 
Lab AG). FCV cDNA was amplified with PhusionTM Hot Start II High-Fidelity DNA 
Polymerase (Thermo Scientific, Waltham, USA) using the published primers AoS 
(forward) and AoA (reverse) (33), which results in the amplification of 1945 
nucleotides (nt) of the FCV capsid (VP1) gene (equivalent to nucleotide positions 
5326 to 7270 of the FCV F9 reference strain; GenBank accession number M86379). 
The PCR reaction comprised 5 μL 5× Phusion HF Buffer, 0.5 μl dNTPs (10 mM), 
0.625 μL primer AoS (20 μM) and 0.625 μL primer AoA (20 μM), 0.25 μL Phusion Hot 
Start II Polymerase (2 U/μL) and 2.5 μL of template cDNA brought up to 25 μL with 
RNase/DNase-free molecular biology grade water (Axon Lab AG). The PCR thermal 
cycling conditions were as follows: 30 sec at 98°C, 40 cycles of 10 sec at 98°C, 30 
sec at 53°C and 90 sec at 72°C, followed by a final elongation for 10 min at 72°C.  
In 17 samples, PCR amplification with the above-mentioned protocol failed. These 
samples were therefore amplified with the SuperScript® III One-Step RT-PCR 
System and the Platinum® Taq DNA polymerase (Invitrogen, Basel, Switzerland) 
using the primers AoS and AoA (33), which resulted in the successful amplification of 
8/17 samples. For PCR amplification, the following reaction mixture was used: 12.5 
μL 2× reaction Mix, 0.625 μL RNasin® Plus RNase Inhibitor (40 U/μL), 0.25 μL 
primer AoS (20 μM) and 0.25 μL primer AoA (20 μM), 1.0 μL SuperScript® III 
Platinum® Taq DNA polymerase and 5 μL of template TNA made up to 25 μL with 
RNase/DNase-free molecular biology grade water (Axon Lab AG). The RT step was 
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performed at 60°C for 30 min, followed by PCR amplification with an initial step at 
94°C for 2 min, 40 cycles of 94°C for 15 sec, 53°C for 30 sec and 68°C for 150 sec, 
followed by 68°C for 5 min. The synthesis of cDNA and the conventional PCR were 
run on a Biometra TPersonal thermal cycler (BioLabo Scientific Instruments, Châtel-
Saint-Denis, Switzerland). For each PCR run, the negative and positive controls were 
included to monitor for cross contamination and successful PCR amplification.  
The PCR products were separated on a 1.5% agarose gel, and bands of the 
appropriate size (1945 bp) were excised and eluted with a QIAquick® Gel extraction 
kit (Qiagen) using 100 μL elution buffer. For sequencing, the amplification primers 
AoS and AoA (33) and newly designed internal primers were used (S_FCV_La.543f: 
5’-GCT-TGG-TCT-GGM-TCT-ATT-GA-3’; S_FCV_Fl.1265r: 5’-GCC-AAC-CAT-CAG-
GTA-TGC-CT-3’; FCVSeq_6145_6164f: 5’-CAY-YTD-ATG-TCT-GAY-ACT-GA-3’; 
FCVSeq_5749_5768f: 5’-GAR-CCH-ARY-KCH-CAA-ATG-TC-3’; 
FCVSeq_6705_6725r: 5’-GGR-ATK-GTD-GTR-TCD-GGC-CA-3’). Sequencing was 
performed at a commercial laboratory (Microsynth, Balgach, Switzerland) under 
standard conditions. Because direct sequencing of the capsid (VP1) gene was not 
successful in five samples (Nos. 52, 68, 100, 145 and 155), the PCR products of 
these samples were cloned using a Topo® TA Cloning® Kit with the pCR™ II-
TOPO® vector and TOP10F’ One Shot® E.coli bacteria (Invitrogen, Basel, 
Switzerland). Correct insertion of the PCR product was checked by EcoRI (Thermo 
Scientific) digestion analysis, and plasmid DNA was purified with a Qiaprep® Spin 
Miniprep Kit (Qiagen) according to the manufacturer’s instructions. The inserted PCR 
products were sequenced at a commercial laboratory (Microsynth) using the 
sequencing primers described above. 
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Sequence alignment and phylogenetic analyses 
All sequences were assembled, and a consensus sequence for each sample was 
obtained using Geneious 7.1.8 (34). The capsid (VP1) gene sequences of the 
vaccine strains FCV G1 and FCV 431 were provided by the manufacturer (Merial, 
Lyon, France). Reference FCV sequences from Europe, North America, Asia and 
Oceania were retrieved from GenBank. The European reference sequences included 
isolates from four cats from Switzerland or Liechtenstein that showed clinical signs 
compatible with virulent systemic disease (11). Codon-based multiple alignment of 
the capsid (VP1) nucleotide sequences was performed using MAFFT (35). 
Nucleotide sequence saturation tests were performed in Dambe (36), which 
implements Xia et al.’s test of nucleotide substitution saturation (37, 38). This test 
indicated that the 3rd codon positions in the nucleotide alignment were not saturated. 
The full nucleotide alignment was retained and used in phylogenetic analyses.  
Bayesian and maximum likelihood (ML) phylogenetic trees were estimated from the 
nucleotide alignment with MrBayes (39) (with 10,000,000 generations and 25% 
burnin) and RAxML (40), respectively. In both cases, the GTR + G + I substitution 
model and parameters selected by jModelTest2 were used (41). Statistical support 
for nodes in the ML phylogeny was assessed using a bootstrap approach with 100 
replicates. The trees were midpoint rooted. Given the known sampling dates of each 
isolate, the temporal signal of the phylogenies was assessed using TempEst (42). A 
regression of the sampling date against the root-to-tip genetic distances indicates 
that the data set contains insufficient temporal signal to justify the use of a 
phylogenetic molecular clock model (data not shown). The isolates were classified 
into FCV “strains” using the previously defined nucleotide distance threshold of 20% 
for variable region E of the capsid (VP1) gene (23, 25). Pairwise genetic distances 
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among isolate sequences were calculated using the function “dist.dna” (Jukes-Cantor 
model, JC69) implemented in the R package “ape” (43). Lineages were defined as 
well-supported clades containing at least two multiple-isolate strains. 
Phylogeny-trait correlation and ancestral character estimations 
Possible correlations between phylogenetic tree structure and trait values for each 
isolate (e.g., sampling location, vaccination status; see Tables 1-4) were assessed 
using the methods implemented in BaTS (44). Trait values were randomized 100 
times to yield a null distribution for hypothesis testing. A correlation was considered 
unambiguously positive if both the association index (AI) and the parsimony score 
(PS) statistics rejected the null hypothesis with p ≤ 0.01. Phylogenetic uncertainty 
was taken into account by using the set of tree topologies estimated by Bayesian 
phylogenetic inference (MrBayes). For those traits that were significantly clustered on 
the FCV phylogeny, parsimonious ancestral character state estimation was 
performed using the function “pace” implemented in the R package “phangorn” (45). 
Comparison between genetic and geographical distances 
Pairwise genetic distances between isolate sequences were calculated as described 
above. Geographical distances between each pair of isolates were calculated using 
the postcodes for each isolate and an online distance calculator 
(http://distancecalculator.globefeed.com). A quadratic assignment procedure 
correlation was used to test for a relationship between the genetic distance (%) and 
the geographical distance using the function “qaptest” implemented in the R package 
“sna” (46). This method computes standard measures of correlation between the 
genetic and geographic distance matrices and then computes an estimate of the 
significance of the correlation by permuting the elements of one of the matrices 5,000 
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times and counting the number of correlations between the observed and permuted 
matrices that are larger or smaller than the empirical estimate. The genetic and 
geographic distance matrices were plotted and visualized using the function “hexbin” 
implemented in the R package “hexbin” (47). 
Statistical analysis  
The exposure variables between pedigree and non-pedigree cats were compared 
using a Chi-squared (pχ2) test or a Fisher’s exact test (pF) for small numbers (n < 5) 
and Analyse-it® for Microsoft Excel 4.51 (Analyse-it Software Ltd., Leeds, United 
Kingdom, http://www.analyse-it.com). Proportions and 95% confidence intervals (CI) 
were calculated using GraphPad Prism® version 6 for Windows (GraphPad 
Software, San Diego, CA, USA, http://www.graphpad.com). Variables such as the 
age of the cats were compared between the two groups using the Wilcoxon-Mann-
Whitney test (pMWU). P-values < 0.05 were considered statistically significant. The 
maps were produced using QGIS Geographic Information System (version 2.8.1) 
(48). Canton boundaries were obtained from the Swiss Federal Office of Topography 
(http://www.swisstopo.admin.ch). 
Sequence accession numbers 
All sequences from this study were submitted to GenBank under the accession 
numbers KU747015-KU747078, KP862870 and KP862872. 
Results 
Characteristics of the study population 
A total of 75 FCV isolates collected during a previous nationwide FCV study (13) and 
originating from four healthy cats and 71 cats with suspected infection were included 
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in this study. Amplification of the PCR product and sequencing was successful for 66 
FCV isolates from three healthy cats and 63 cats with suspected infection (Tables 1-
3). The 66 cats were sampled in 22 veterinary practices located in 17 out of 26 
cantons in Switzerland (Figure 1). The geographic distance (based on the postcodes) 
between the veterinary practices ranged from 4.7 km to 240 km (median = 92.4 km), 
and the distance between cat owners ranged from 0 km (same village) to 250 km 
(median = 95 km). Out of the 66 cats, 21 (32%) were pedigree cats; they belonged to 
seven different breeds (11 Maine Coons, 4 Norwegian Forest cats, 2 British Shorthair 
cats and 1 each of Oriental, Persian, Sacred Birman and Siamese cats). Fifty cats 
(78%) lived in multi-cat households (households with ≥ 2 cats), and 38 cats (59%) 
had outdoor access. Most of the cats were vaccinated against FCV (n = 46; 73%), 
and most had received at least a primary immunization (defined as two subsequent 
vaccinations within two to six weeks with the same vaccine strain, n = 33; 59%). 
Stomatitis, gingivitis or caudal stomatitis were the most common clinical signs (n = 
48; 73%), and co-infections with other upper respiratory tract-associated pathogens 
were present in 44 (67%) of the cats. 
FCV phylogeny and strain identification 
Phylogenetic analysis included 66 nearly complete capsid (VP1) gene sequences 
(1700-1800 nt) from naturally infected cats, four FCV vaccine strains (FCV F9, FCV 
255, G1 and 431) and 37 reference FCV sequences retrieved from GenBank. In 
general, the genetic heterogeneity among the capsid (VP1) gene sequences of the 
FCV isolates was very high. The resulting codon-based nucleotide alignment showed 
that individual nucleotides and their corresponding amino acid sites were either 
invariant or highly variable (data not shown). The estimated FCV phylogenies 
(Bayesian tree in Figure 2; ML tree in Supplementary Figure 1) were in accordance 
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with these sequence properties. Specifically, there was a notable lack of phylogenetic 
structure, and most of the internal nodes close to the root were poorly supported, 
with Bayesian posterior probabilities of < 0.8 and ML bootstrap scores of < 50%. A 
common property of these phylogenies was that their topologies exhibited short 
external branches and long internal branches. Further, the estimated Bayesian and 
ML topologies were incongruent. To quantify this, we placed the ML tree bootstrap 
scores onto the estimated Bayesian phylogeny (Figure 2 and Supplementary Figure 
1), which illustrates the topological incongruences between the two phylogenies, 
especially at more ancestral nodes. Nodes near the tree tips tended to be better 
supported, with high Bayesian posterior probabilities closer to 1.0 and ML tree 
bootstrap scores > 50%.  
Using a pairwise nucleotide genetic distance threshold of 20% in variable region E of 
the capsid (VP1) gene sequence, the isolates were assigned to 52 strains. Most of 
the strains (81%) were defined by only one isolate, with the exception of 10 strains 
(A-J) that contained two to three isolates (Figure 2). Within these multi-isolate strains 
(A-J), the pairwise genetic distances in variable region E of the FCV isolates ranged 
from 2% to 20%. Remarkably, both the Bayesian and the ML phylogenies showed 
two well-supported lineages above the strain level (denoted lineages 1 and 2 in 
Figure 2 and Supplementary Figure 1; Bayesian posterior probability = 1.0 and 
bootstrap scores > 80%). Lineage 1 comprised isolates from strains B and C and five 
single-strain FCV isolates. Lineage 2 comprised isolates from strains F-J plus 
fourteen single-strain FCV isolates. Both lineages contained not only FCV isolates 
from this study but also reference FCV isolates from a previous study from cats from 
Switzerland or Liechtenstein, which neighbours Switzerland (11). Outside these two 
lineages, the nodes that represent the common ancestor strains containing multiple 
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isolates (i.e., strains A, D and E) were well-supported, with Bayesian posterior 
probabilities = 1.0 and ML bootstrap scores equal to 100%. Conversely, within 
lineages 1 and 2, the nodes that represent the common ancestor of each multi-
isolate strain were well-supported in some instances (C, I and J) but poorly supported 
in others (B, F, G and H), indicating a difference between the genetic and patristic 
distances. The internal nodes within strains A, C, F and H tended to be supported 
with Bayesian posterior probabilities > 0.8 but not with bootstrap scores > 80%, 
whereas most of the nodes between the strains were poorly supported (Bayesian 
posterior probability < 0.8 and bootstrap scores < 50%).  
The geographic origin of the FCV isolates assigned to different strains and lineages 
is indicated in Figures 3a and 3b, respectively. The maximal geographic distance 
between FCV isolates within a given strain (based on the postcodes of the cat 
owners) ranged from 0 km (strain J) to 209 km (strain F). Both isolates of strain J 
(isolates 32 and 145) were derived from one village, and all isolates of strains A 
(isolates 49, 83 and 106) and D (isolates 68 and 155) were from the same canton in 
Switzerland.  
All reference sequences retrieved from GenBank that were included in the 
phylogenetic analyses were placed outside strains A-J, except for the FCV vaccine 
strain F9, which was located in strain D together with two isolates of this study 
(isolates 68 and 155). These two isolates were obtained from the same veterinary 
practice and from two cats that had received a FCV vaccination (with Feligen® CRP, 
Virbac; containing FCV F9 vaccine strain) 41 days and 70 days prior to sample 
collection.  
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Association of FCV phylogeny with different traits 
All traits listed in Tables 1-3 and the "veterinary practice" trait were tested for 
association with FCV phylogeny. For each trait, we tested whether we could reject 
the null hypothesis that the trait is randomly distributed with respect to the tree 
topology.  
A strong statistical association was found between the FCV phylogeny and the 
“pedigree” trait (Table 1; p < 0.01 using the AI and PS statistics). Ancestral character 
state estimation of this trait showed that most of the FCV isolates (17 out of 21) from 
pedigree cats belonged to lineage 2 and formed a monophyletic clade dominated by 
pedigree cats (Figure 4). Within lineage 2, 10 of the 17 FCV isolates from pedigree 
cats were derived from Maine Coon cats, which was the predominant breed in our 
study population. Within lineage 2, eight isolates from pedigree cats belonged to 
strains F, G, H and I, and nine isolates represented single-isolate strains. The 
remaining four isolates from pedigree cats were single-isolate strains located outside 
of lineages 1 and 2. The association of FCV phylogeny with "pedigree cat" could not 
be explained by a geographical clustering of the pedigree cats because the cats 
originated from 11 different cantons, and the samples were collected in 14 different 
veterinary practices (Figure 1). Furthermore, when the genetic distance of pedigree 
and non-pedigree isolates was separately compared to geographic distances 
between owners or veterinary practices, no correlation was found (Supplementary 
Figure 2). We further assessed whether the pedigree cats in this study exhibited 
some characteristics that were different from the non-pedigree cats that could 
potentially account for the observed association of the “pedigree” trait with FCV 
phylogeny (Supplementary Table 1). The analysis revealed that the pedigree cats 
were more commonly kept by cat breeders (pχ2 < 0.01), lived more commonly in 
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multi-cat households (pχ2 = 0.02) and without outdoor access (pχ2 < 0.01), and were 
less commonly treated with immunosuppressive (pχ2 = 0.02) and antibiotic 
medications (pχ2 = 0.04) than non-pedigree cats. The pedigree cats had more 
commonly received a primary immunization against FCV ( pχ2 = 0.03), and the FCV 
vaccine strains used for immunization were different from those used for the non-
pedigree cats (pχ2 < 0.01). Furthermore, pedigree cats more commonly suffered from 
lingual and oral ulcerations (pχ2 < 0.01; data not shown) than the non-pedigree cats.  
There was also a significant association of the “veterinary practice” trait with FCV 
phylogeny (p < 0.01 using AI statistic, p = 0.05 using PS statistics). Ancestral state 
reconstruction indicated that some multi-isolate strains (strains A, D and J) were 
localised to individual veterinary practices; for strain C, two out of the three isolates 
came from the same practice (Figure 4). The time span between collections of 
closely related isolates within one veterinary practice ranged from six days (strain C; 
isolates 65 and 81) to seven weeks (strain J; isolates 32 and 145). The FCV isolates 
within the remaining six multi-isolate strains derived from different Swiss cantons and 
were collected in different veterinary practices. Overall, the strain diversity collected 
in each veterinary practice was high: in 19 out of 22 veterinary practices, the number 
of collected samples was equal to the number of FCV strains. 
Looking at the different forms of husbandry type (private, cat breeder and others), the 
association with FCV phylogeny was inconclusive (p = 0.02 using the AI statistic; p = 
0.2 using the PS statistic; Table 1). A questionable statistical association with FCV 
phylogeny was also found for the "primary FCV immunization" trait (p = 0.06 using 
the AI statistic, p = 0.02 using the PS statistic, Table 2). Finally, there was an 
inconclusive association of FCV phylogeny with the vaccine strain used for 
immunization (p = 0.04 using the AI statistic, p = 0.08 using the PS statistic, Table 2). 
21 
 
Because "pedigree" was significantly associated with husbandry type, primary 
immunization of the cats and the vaccine strain used for immunization 
(Supplementary Table 1), these associations could have acted as confounding 
variables in the single-trait analyses. All other variables investigated in this study 
showed no significant association with FCV phylogeny (Tables 1 - 3). 
Correlation between pairwise genetic and geographical distances  
Given the weak statistical support for many phylogenetic nodes, we further explored 
the spatial clustering of FCV isolates by plotting pairwise genetic distances against 
pairwise geographical distances (Figure 5). Pairwise geographical distances were 
calculated between the locations of the cat owners and also between the locations of 
the veterinary practices where the samples had been collected. We observed weak 
associations between genetic and spatial distances in both cases (Pearson 
correlation r = 0.036, p = 0.245 for distances between cat owners; Pearson 
correlation r = 0.033, p = 0.268 for distances between veterinary practices).  
Discussion 
Investigating the genetic diversity and phylogeny of FCV isolates is a prerequisite to 
understanding the epidemiology and pathogenesis of FCV and may assist in the 
development of efficacious vaccine strategies. This study provides, for the first time, 
a nationwide analysis of FCV isolates based on the nearly complete capsid (VP1) 
gene. We identified 52 different strains circulating in the Swiss cat population and two 
well-supported lineages above the strain level that contained 24 and 9 isolates. The 
remarkably high strain diversity observed in the present study is in agreement with 
three recent studies that addressed FCV phylogeny within communities (49), at the 
country level in the UK (27) and in different European countries (28). These three 
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studies were all based on partial capsid (VP1) gene sequences (i.e., variable regions 
C and E of the ORF2 of FCV) (27, 28, 49) and were hampered by a lack of 
phylogenetic signal above the strain level caused by sequence saturation. To 
overcome this limitation, in this study, we analysed the almost complete capsid (VP1) 
gene of the FCV isolates, which included more conserved domains of the capsid 
protein. The resolution of the phylogeny in our study was thus greater than in other 
studies (27, 28). Nonetheless, there was still a lack of deep phylogenetic structure; 
most internal nodes close to the phylogeny root were poorly supported, reflecting the 
exceptionally polymorphic nature of variable sites within the FCV capsid (VP1) gene.  
In agreement with previous studies, we found remarkably high strain diversity among 
FCV isolates in Switzerland. Strains containing multiple isolates comprised no more 
than three different isolates, which resulted in a maximum prevalence of 4.5% for any 
given FCV strain of this study. This remarkably high strain diversity is also influenced 
by the strain definition used. In accordance with previous studies, a strain was 
defined by > 20% genetic distance in variable region E of the capsid (VP1) gene and 
included 235 bp of variable region E. This definition is based on studies that showed 
that related FCV isolates in endemically infected colonies show up to 16% genetic 
distance, whereas unrelated isolates show > 20% distance in variable region E of 
VP1 (23, 24). The FCV strain definition therefore applies to closely related isolates 
that are epidemiologically and spatially linked (23, 24). However, it is sometimes 
used ambiguously, as some studies applied the genetic distance definition to 235 bp 
of the variable region E (23, 25), whereas others applied it 420 bp (20) to 529 bp 
amplicons (28, 50) of variable regions C and E. These differences are important 
given the very high variation in genetic diversity among sequence regions within the 
capsid (VP1) gene. Our analyses also identified two well-supported lineages above 
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the strain level, lineages 1 and 2, that included 10 and 26 FCV isolates, respectively. 
The isolates within lineages 1 and 2 showed 15 - 33% and 12 - 34% pairwise genetic 
distances, respectively, in variable region E of the capsid (VP1) gene. Sequences 
with genetic distances >20% that cluster together with bootstrap scores >80% have 
so far only been documented in one study of cats in the UK, but was a rare finding 
(27).  
We identified a strong statistical association between FCV phylogeny and the 
“pedigree” trait. Ancestral character state estimation revealed that 17 out of 21 FCV 
isolates from pedigree cats belonged to lineage 2 and formed a monophyletic and 
well-supported clade mostly comprising pedigree cats, indicating an epidemiological 
link between these isolates. It could be hypothesized that pedigree cats represent a 
new environmental niche to which FCV might become adapted. To the best of our 
knowledge, this is the first report where FCV genetic diversity has been successfully 
correlated with characteristics of the host. The association with pedigree might be a 
caused by a common route of transmission of FCV strains among pedigree cats in 
Switzerland, e.g., during cat exhibitions or within breeding catteries. Alternatively, 
genetic characteristics of pedigree cats might explain the strong association between 
FCV phylogeny and the “pedigree” trait. Most pedigree cats in this study were Maine 
Coon cats, and 10 out of 11 FCV isolates from Maine Coon cats were located in 
lineage 2. However, FCV isolates from other cat breeds in this study were also 
predominantly placed in lineage 2. Maine Coon cats might be overrepresented in the 
present study because the cat population of this study was not representative of the 
Swiss cat population.  
In agreement with a previous study (27), we found only weak associations between 
the genetic and spatial distances of FCV isolates. This was the case for both the 
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location of the cat owners and the location of the veterinary practices where the 
samples had been collected. Recent studies reported that FCV strains are confined 
to close geographic regions or single countries (27, 28). A study in cats in the UK 
found only two FCV strains detected >100 km apart, and the most widespread strain 
contained only variants of FCV F9, a common FCV vaccine strain. The authors of 
that study concluded that FCV seems to have only limited ability for widespread 
geographic spread and that the movement of persistently infected cats is the most 
likely reason for dissemination (27). In our study, all but one multi-isolate strain 
(exception strain D) and both lineages 1 and 2, contained only isolates from cats 
from Switzerland and Liechtenstein, a neighbouring country of Switzerland. However, 
the maximal geographical distance between FCV isolates of multi-isolate strains was 
209 km (strain F), and geographic distances of >100 km within a multi-isolate strain 
were not uncommon. We only identified two FCV F9 variants (isolates 68 and 155, 
strain D), and in contrast to the UK study, they were not geographically dispersed 
and originated from two cats from the same veterinary practice. There could be 
several reasons for the differences between our results and those of the UK study. 
First, the shorter distances between sampling sites in our study (median 92.4 km) 
compared to the UK study (over 300 km for the majority of practices (27)) allowed us 
to also explore intermediate distances of FCV dissemination. Second, our study 
included a higher percentage (0.004%) of the total national cat population (estimated 
1.5 million cats, http://www.tierschutz.com/publikationen/heimtiere/infothek/katzen_ 
hunde/mb_katzen_kastration.pdf) than the UK study (0.002%, estimated 8 million 
cats, http://www.pfma.org.uk/pet-population-2008-2012), which might have allowed 
us to detect less prevalent FCV strains. Third, only one FCV isolate per household 
was included in our study, whereas isolates collected from cats from the same 
household were included in the UK study, which could have altered the geographical 
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footprint of FCV. Fourth, our study excluded cats with recent FCV vaccination to 
avoid the inclusion of FCV vaccine strains that can occasionally be detected up to 
three weeks after vaccination (51-53). The most geographically widespread FCV 
strains in our study (strains F to I) were predominantly obtained from pedigree cats. 
Pedigree cats might be moved over longer geographic distances, i.e., for breeding or 
for cat exhibitions. The inclusion of a relatively large number of pedigree cats in our 
study could therefore also account for the observed wide geographic dispersal of 
some FCV strains. 
In agreement with a previous study, the overall strain diversity collected in veterinary 
practices was remarkably high (27). In 19 out of 22 practices, the number of collected 
samples was equal to the number of FCV strains. Nevertheless, we found a 
significant association between the “veterinary practice” trait and the FCV phylogeny. 
This association could be because several multi-isolate strains (A, C, D and J) were 
almost exclusively collected in single veterinary practices. The existence of closely 
related FCV isolates in one veterinary practice has also been previously reported 
(27). Indirect transmission of FCV is common, since this non-enveloped RNA virus is 
highly resistant to many disinfectants and can remain infectious for up to one month 
in the environment (54). If hygiene measures are insufficient, indirect transmission 
could play a role in the environment of a veterinary practice. However, this would 
require that the cats were presented and infected in the veterinary practices prior to 
sample collection. Alternatively, contamination of swabs with FCV from the practice 
environment could have caused PCR-positive results. However, all except one of the 
cats from which the isolates of strains A, C, D and J were obtained showed clinical 
signs consistent with FCV infection. Furthermore, all sample collection material was 
provided to the veterinary practices together with detailed instructions on how to 
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properly collect the samples. Finally, the detection of closely related FCV isolates in 
one veterinary practice could reflect the transmission of this FCV strain between cats 
in the catchment area of that practice. The cats infected with variants of the multi-
isolate strains A, D or J lived in rather close proximity to each other (within 16 km 
apart), although this was not the case for the cats infected with variants of strain C 
(up to 62 km apart). Furthermore, only five out of nine cats in strains A, C, D and J 
were allowed outdoors. However, FCV can also be indirectly transmitted between 
cats via fomites, which could have accounted for the infections of the indoor cats.  
Only two isolates closely related to the FCV vaccine strain F9 were detected in this 
study (isolates 68 and 155, strain D); the isolates showed <3% genetic divergence 
from the vaccine strain in the variable region E. Both samples were collected in a 
single veterinary practice and derived from two cats that had been vaccinated with a 
vaccine containing FCV F9 41 and 70 days prior to sample collection, respectively. 
FCV F9 is contained in several modified-live virus vaccines licensed in Switzerland, 
and a short-term oral shedding of FCV F9 for some days up to three weeks after 
vaccination has been reported (51-53). Previous studies have also occasionally 
reported the isolation of FCV F9 variants from the general cat population (27, 50, 55), 
but in contrast to the present study, recent vaccination was not an exclusion criterion 
in these studies. A very recent multinational study of cats from different European 
countries did not detect any isolates related to FCV F9; cats vaccinated within one 
month prior to sample collection were excluded from that study (28). The detection of 
FCV F9 variants in the present study up to 70 days after vaccination could be 
explained by an inadvertent infection of the cats with the FCV vaccine strain, as 
reported after the licking of accidently spilled vaccine material from the fur of the cats. 
In such cases, clinical signs of FCV infection and prolonged shedding of the vaccine 
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virus (several weeks to a few months) can occur (51). Alternatively, the two cats 
might have been exposed to an FCV F9-like field variant, but this seems less likely 
because cat 155 was kept strictly indoors as a single cat and lived 16 km away from 
cat 68. Finally, prolonged shedding of FCV F9 after the correct application of the 
vaccine might occur in cats with a severe immune deficiency. While cat 68 was a 
healthy young cat presented for castration, cat 155 presented with fever, apathy, 
ocular discharge and gingivitis and tested PCR-positive for feline immunodeficiency 
virus (FIV) in RT-qPCR (13). However, it seems improbable that immunosuppression 
due to FIV infection explains the extended time of shedding of FCV after vaccination 
in cat 155. Prolonged FCV shedding was not observed in FIV-positive cats in an 
experimental study (56), and severe immunodeficiency usually occurs only during 
long-term FIV infection (57); cat 155 was only five months old at the time of sampling.   
Conclusion 
Our study indicates that FCV lineages above the strain level can sometimes be 
identified if genetic data from more conserved regions of the FCV genome are 
included in phylogenetic analyses. FCV phylogeny was significantly associated with 
the pedigree status of the sampled animals, and the isolates from most pedigree cats 
were placed in lineage 2 in this study. All but one strains and both lineages identified 
in this study were restricted to cats in Switzerland or Liechtenstein. Within 
Switzerland, we observed a greater geographic dispersal of FCV strains than 
previously reported. Variants of the FCV F9 vaccine strain were very rarely detected 
and may be assigned to the inadvertent infection of cats by oral intake of spilled 
vaccine material. The resolution of the FCV phylogeny in this study was greater than 
that in previous studies, which can be attributed to the use of more conserved 
regions of the capsid (VP1) gene. Nonetheless, phylogenetic analyses were still 
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hampered by sequence saturation. To overcome this limitation and to further resolve 
the phylogenetic relationships of FCV isolates, future studies should extend genetic 
analyses to longer sequences of FCV. 
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Figure legends 
Figure 1: Map of Switzerland and its cantons, showing the origin of the FCV isolates 
sequenced in this study. Coordinates were calculated using the home address of the 
cat owners, and the map was produced using QGIS (48). 
Figure 2: Bayesian phylogenetic tree estimated from 109 FCV capsid (VP1) gene 
nucleotide sequences, including reference isolates and isolates from this study. 
Statistical support for phylogenetic nodes corresponds to the Bayesian posterior 
probabilities and ML bootstrap scores (100 replicates, see Supplementary Figure 1), 
separated by the slash character. Hyphens replace posterior probabilities <0.8 and 
bootstrap scores <50%. Tip labels are coloured by sampling locations: Swiss isolates 
from this study are in red, European reference isolates in green, North American 
reference isolates in blue, Oceanian reference isolates in purple, and Asian reference 
isolates in brown. Grey boxed areas denote multi-isolate strains A to J (for details 
see text). Minimum-maximum genetic diversity (%) and minimum-maximum 
geographical distances (km) within each multiple-isolate strain are indicated next to 
the corresponding strain name. Circled numbers indicate denoted lineages 1 and 2. 
Figure 3: Maps of Switzerland and its cantons displaying (a) the distribution of the 
multi- and single-isolate strains and (b) the distribution of the FCV isolates assigned 
to lineage 1, 2 or no lineage. Both isolates of strain J originated from the same village 
and are indicated as a single dot in Figure 3a. Coordinates were calculated using the 
home address of the cat owners, and the map was produced using QGIS (48). 
Figure 4: Bayesian FCV phylogenetic tree upon which ancestral trait state 
reconstructions have been superimposed. Tip circles in red and in blue show FCVs 
isolated from non-pedigree cats and pedigree cats, respectively. Node circles 
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indicate the parsimonious ancestral trait state reconstruction of the “pedigree” trait. 
Dashed branches represent lineages for which ancestral character state 
reconstruction of the “veterinary practice” trait was non-ambiguous. The colours of 
the dashed branches correspond to the veterinary practices. 
Figure 5: Comparison of pairwise genetic distances (%) and pairwise geographical 
distances obtained from the isolates in this study using variable region E of the 
capsid (VP1) gene. Panel A shows the correlation obtained if the pairwise geographic 
distances are calculated between the locations of the cat owners, and panel B shows 
the correlation obtained if the pairwise geographic distances are calculated between 
the locations of the veterinary practices.  
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Tables 
Table 1: Characteristics of the 66 FCV-positive cats and association with FCV 
phylogeny. P values < 0.05 are shown in bold. 
Parameter Median Lower 
95% CI# 
Upper 
95% CI# 
AI& (P 
value) 
PS§ (P value) 
Age (years) 3.8 0.25 13.7   
 Parameter Proportio
n 
Lower 
95% CI# 
Upper 
95% CI# 
AI& (P 
value) 
PS§ (P value) 
Sex (male) 0.62 0.49 0.74 0.13 0.26 
Intact reproductive 
status*  
0.46 0.33 0.59 0.62 0.81 
Pedigree 0.32 0.21 0.44 < 0.01 < 0.01 
Breed    < 0.01 < 0.01 
Maine Coon 0.17 0.09 0.28   
British Shorthair 0.03 0.00 0.11   
Norwegian Forest 
Cat 
0.06 0.02 0.15   
Other breeds 0.06 0.02 0.15   
Multi-cat household* 0.78 0.66 0.88 0.56 0.24 
Group size*    0.22 0.23 
with 2-3 cats/group 0.40 0.28 0.53 
  with 4-5 cats/group 0.16 0.08 0.27 
>5 cats/group 0.22 0.13 0.35 
Husbandry type    0.02 0.2 
Private 0.79 0.67 0.88   
Cat breeder 0.09 0.03 0.19   
Other husbandry 0.12 0.05 0.23   
Outdoor access* 0.59 0.46 0.71 0.56 0.12 
Immunosuppressive 
therapy 
0.15 0.08 0.26 0.43 0.31 
Antibiotic therapy 0.32 0.21 0.44 0.16 0.23 
Antiviral therapy* 0.03 0.00 0.11 0.25 1.0 
#CI, confidence interval, &AI, association index, § PS, parsimony score, *data missing 
for single cats (reproductive status, n = 5; multi-cat household, n = 2; group size, n = 
3; outdoor access, n = 1, antiviral therapy, n = 1)
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Table 2: FCV vaccination status of the 66 FCV-positive cats and association 
with FCV phylogeny. P values < 0.05 are shown in bold. 
 Parameter Proportio
n 
Lower 
95% CI# 
Upper 
95% CI# 
AI& (P value) PS§ (P 
value) 
FCV-vaccinated* 0.73 0.43 0.68 0.38 0.25 
FCV vaccine strain*    0.04 0.08 
F9 0.32 0.21 0.45   
Purevax 0.06 0.02 0.16   
Other vaccine 
strain 
0.35 0.23 0.48   
Primary 
immunization‡ 
0.59 0.45 0.72 0.06 0.02 
#CI, confidence interval, &AI, association index, § PS, parsimony score, *data missing 
for single cats (FCV vaccination status, n = 3; FCV vaccine strain, n = 3; primary 
immunization, n = 10), ‡primary immunization was defined as two subsequent 
vaccinations within 2 to 6 weeks with the same FCV vaccine strain
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Table 3: Health status, clinical signs and co-infections with other upper 
respiratory tract-associated pathogens in the 66 FCV-positive cats and 
association with FCV phylogeny.  
Parameter Proportio
n 
Lower 
95% CI# 
Upper 
95% CI# 
AI& (P 
value) 
PS§ (P 
value) 
Healthy 0.05 0.01 0.13 0.31 1.0 
Sneezing and/or 
nasal discharge* 
0.32 0.21 0.45 0.61 0.93 
Conjunctivitis and/or 
ocular discharge 
0.39 0.28 0.52 0.44 0.31 
Salivation 0.38 0.26 0.51 0.79 0.87 
Lingual and/or oral 
ulcerations 
0.30 0.20 0.43 0.79 0.31 
Stomatitis and/or 
gingivitis and/or 
caudal stomatitis 
0.73 0.60 0.83 0.25 0.52 
Cutaneous 
ulcerations and/or 
cutaneous oedema 
0.05 0.01 0.13 0.07 1.0 
Limping and/or 
swollen joints 
0.06 0.02 0.15 0.25 1.0 
M. felis PCR-positive 0.56 0.43 0.69 0.06 0.06 
FHV-1 PCR-positive 0.23 0.13 0.35 0.25 0.62 
C. felis PCR-positive 0.05 0.01 0.13 0.25 1.0 
B. bronchiseptica 
PCR-positive 
0.05 0.01 0.13 0.43 1.0 
#CI, confidence interval, &AI, association index, §PS, parsimony score, *data from one 
cat missing 
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Appendix 
Supplementary Table 
Comparison of characteristics between the 45 non-pedigree and the 21 pedigree 
cats. P values < 0.05 are shown in bold. 
 Non-pedigree cats (n = 
45) 
Pedigree cats (n = 21)  
Parameter Median Lower 
95% 
CI# 
Upper 
95% 
CI# 
Median Lower 
95% 
CI# 
Upper 
95% 
CI# 
P 
value 
Age (years) 5.0 0.35 15.40 1.75 0.18 9.08 0.10 
Parameter Propor-
tion 
Lower 
95% 
CI# 
Upper 
95% 
CI# 
Propor-
tion 
Lower 
95% 
CI# 
Upper 
95% 
CI# 
P 
value 
Sex (male)  0.67 0.51 0.80 0.52 0.30 0.74 0.27 
Intact reproductive* 
status  
0.45 0.30 0.61 0.47 0.24 0.71 0.88 
Multi-cat household*  0.70 0.54 0.83 0.95 0.76 1.00 0.02 
Group housing*       0.16 
2-3 cats/group 0.43 0.28 0.59 0.33 0.15 0.57  
4-5 cats/group 0.10 0.03 0.23 0.29 0.11 0.52  
>5 cats 0.17 0.07 0.31 0.33 0.15 0.57  
Husbandry type       <0.01 
Private 0.82 0.68 0.92 0.71 0.48 0.89  
Cat breeder 0.00 0.00 0.00 0.29 0.11 0.52  
Other husbandry 0.18 0.08 0.32 0.00 0.00 0.00  
Outdoor access* 0.75 0.60 0.87 0.24 0.08 0.47 <0.01 
Immunosuppressive 
therapy  
0.22 0.11 0.37 0.00 0.00 0.00 0.02 
Antibiotic therapy  0.40 0.26 0.56 0.14 0.03 0.36 0.04 
Antiviral therapy* 0.02 0.00 0.12 0.05 0.00 0.25 0.55 
FCV-vaccinated* 0.67 0.52 0.81 0.85 0.62 0.97 0.14 
FCV vaccine strain*       0.01 
F9 0.21 0.10 0.36 0.55 0.32 0.77  
Purevax 0.02 0.00 0.12 0.15 0.03 0.38  
Others 0.44 0.29 0.60 0.15 0.03 0.38  
Primary 
immunization*,‡ 
0.49 0.32 0.66 0.79 0.54 0.94 0.03 
#CI, confidence interval, * data missing for single cats (reproductive status, n = 5; 
multi-cat household, n = 2; group housing, n = 3; outdoor access, n = 1; antiviral 
therapy, n = 1; FCV vaccination, n = 3; FCV vaccine strain, n = 3; primary 
immunization, n = 10), ‡primary immunization was defined as two subsequent 
vaccinations within 2 to 6 weeks with the same FCV vaccine strain 
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Supplementary Figures 
Supplementary Figure 1: Maximum likelihood phylogenetic tree estimated from 109 
FCV capsid gene nucleotide sequences, including reference isolates and isolates 
from this study. Statistical support for the phylogenetic nodes was assessed using a 
bootstrap approach (100 replicates).  
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Supplementary Figure 2: Comparison of pairwise genetic distances (%) and 
pairwise geographical distances obtained from the isolates in this study based on 
variable region E of VP1. Panels A and C show the correlations obtained if the 
pairwise geographic distances were calculated between the locations of the cat 
owners and included only samples isolated from non-pedigree cats. Panels B and D 
show the correlations obtained if the pairwise geographic distances were calculated 
between the locations of the veterinary practices and included only samples isolated 
from pedigree cats. 
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